type 2 diabetes
Conditions
Interventions
All participants wore a sensor(Free Style Libre Pro) more than 7-day baseline period, during this phase sensor glucose measurements were blinded (not visible) to participants and investigators. Then p
D015190
Sponsors
Arima Hiroshi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Outpatiants with type 2 diabetes whose HbA1c is 7.5% or more and less than 8.5% Aged 20 years or older and under 70 No serious diabetic complications Agreed with the protocol of this study.
Exclusion criteria
Exclusion criteria: Dialysis patients Patients treated with insulin therapy Patients conducting self-blood glucose measurement Patients with diabetic nephropathy phase 4 or higher Patients with diabetic retinopathy more than pre-proliferative retinopathy Patients who can not properly operate the device Patient judged inappropriate for participation in this study by doctors
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c | — |
Secondary
| Measure | Time frame |
|---|---|
| Body weight, blood pressure, change of antidiabetic agent, fasting blood glucose, Lipid (total cholesterol, LDL, HDL, TG), uric acid, urinary albumin. The Diabetes Treatment Satisfaction Questionnaire (DTSQ) at 3 month endpoint Data of glucose fluctuations at baseline and 3 months endpoint obtained from FGM Measurement frequency of FGM and SMBG, measurement time Adverse event Relationship between glucose fluctuations data at baseline obtained from FGM and characteristics of participants Exploratory study: Relationship between patient background / clinical indicators and intervention effect | — |
Contacts
Public ContactTakeshi onoue
Nagoya University Hospital
Outcome results
None listed